7 Best Peptide Telehealth Providers in Delaware (2026)

Introduction

The best peptide telehealth providers serving Delaware in 2026 are TrimRx, FormBlends, Eden, HealthRX.com, Strut Health, Hims, and Mochi Health. Peptide telehealth in Delaware fills a real vacuum. The state has fewer than a million residents, an adult obesity rate of 37.9% (CDC BRFSS 2023), and almost no dedicated metabolic, longevity, or sports peptide clinics of its own. Wilmington patients have historically driven to Philadelphia’s Main Line for that care. Telehealth ends the commute.

Sort the category before choosing. GLP-1 peptides (semaglutide, tirzepatide) are proven drugs with phase 3 trials. Wellness peptides (sermorelin, NAD+, BPC-157) run on early or animal-stage evidence, and honest providers say that out loud. Both require prescriptions; only the first group has results you can take to the bank.

At TrimRx, we believe understanding what’s actually available is the first step toward a health journey you can manage. The free assessment quiz takes about five minutes if you’re curious whether a personalized program fits.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Comparison Table

Quick Answer: Delaware Code Title 24, Chapter 17, Section 1769D authorizes telehealth prescribing after a relationship is established through real-time audiovisual technology, with no in-person visit needed for peptides.

How We Ranked for Delaware

The bar was identical for every candidate: a named prescriber licensed for Delaware reviewing each order, sourcing from registered 503A or 503B compounding pharmacies, pricing that holds up past the first month, follow-up care from actual clinicians, and breadth of peptide selection. Small-state coverage was a hidden filter, since some telehealth operators skip low-population states entirely when arranging licensure. Everyone listed serves Delaware patients.

1. TrimRx

TrimRx leads for Delaware because its program brings big-market clinical structure to a state the specialty clinics skipped. It starts with a free assessment quiz. A clinician licensed for Delaware then reviews your history, medications, and labs through a real-time visit consistent with Section 1769D before any prescription. Core programs are compounded semaglutide from $199 a month and compounded tirzepatide from $349, both from FDA-registered 503A compounding pharmacies with patient-specific personalization documented, as post-shortage FDA rules require.

These two peptides hold the category’s only large-scale proof: 14.9% mean weight loss in STEP 1 (Wilding et al. 2021, NEJM) and 20.9% in SURMOUNT-1 (Jastreboff et al. 2022, NEJM), plus SELECT’s 20% cardiovascular event reduction (Lincoff et al. 2023, NEJM). Titration runs 16 to 20 weeks with monthly check-ins, and refrigerated shipping covers all three counties in a day or two. The honest limitation: the non-GLP-1 peptide menu is still growing, so recovery-compound shoppers should check the next entry.

2. FormBlends

FormBlends replaces the Main Line clinic trip entirely. Its published catalog at formblends.com runs from compounded GLP-1s through BPC-157, TB-500, CJC-1295 with ipamorelin, sermorelin, NAD+, and GHK-Cu, all prescribed via physician-supervised intake and filled by an FDA-registered 503A compounding pharmacy, with batch testing posted per product page.

Who it fits: Delaware patients who want recovery or longevity compounds plus metabolic care from a single provider, without crossing into Pennsylvania for it. The honest limitation is its newness: less operating history than legacy telehealth brands, so run the standard pharmacy and prescriber verification. Pricing is per compound rather than a flat membership.

3. Eden

Eden delivers the two most requested wellness peptides at flat published rates: doctor-prescribed sermorelin from about $96 a month and NAD+ injections from around $145, consults and shipping included, with pricing that doesn’t climb as doses titrate.

Who it fits: First State patients who want secretagogue or NAD+ support without Philadelphia med spa pricing. The limitation is range: sermorelin, NAD+, and GLP-1 programs cover most of the menu, so anyone building a broader stack needs a second provider.

4. HealthRX.com

HealthRX.com presents its GLP-1 programs and peptide range as an open storefront you can browse before any consult, with a licensed provider reviewing each order before shipment. For a small state with no local clinics to walk into, seeing the full menu upfront is a genuine service.

Who it fits: comparison shoppers who want product visibility before commitment. Pricing is shared at consult and checkout rather than published flat. The honest limitation is the thin public review footprint of a newer entrant, so confirm the dispensing pharmacy and prescriber licensing before paying.

5. Strut Health

Strut Health holds the budget tier with sermorelin from $99 a month and NAD+ from about $149, with free physician visits and free follow-up per published pricing. Its main business remains compounded hair, skin, and sexual wellness medication.

Who it fits: price-first patients managing simple protocols. The limitation: peptides are a side menu here, so expect lighter monitoring than metabolic-focused providers offer.

6. Hims

Hims supplies compounded semaglutide around $199 a month per published pricing inside the most familiar consumer health app in the country. GLP-1s are peptides, so it earns a slot for Delawareans focused on weight alone.

Who it fits: first-time users who want a known brand and simple subscription billing. The limitation: no recovery or longevity catalog whatsoever.

Key Takeaway: The state has almost no in-person peptide or longevity clinic infrastructure, so telehealth is the default access route rather than the alternative.

7. Mochi Health

Mochi Health wraps compounded semaglutide ($99 a month for medication plus a $69 to $79 membership, about $178 all-in per published comparisons) around unlimited visits with obesity-trained physicians.

Who it fits: patients who want recurring live appointments rather than messaging-based care. The limitation: two-line billing costs more than medication-only competitors, and the scope is GLP-1 only.

Is Peptide Telehealth Legal in Delaware?

Yes. Delaware Code Title 24, Chapter 17, Section 1769D authorizes telehealth, and a Delaware-licensed provider can establish the patient relationship through real-time audiovisual technology and then prescribe non-controlled medications, which includes GLP-1s and therapeutic peptides. The federal Ryan Haight Act applies only to controlled substances, so no in-person exam is required.

The standard of care still applies in full: history review, medication reconciliation, and contraindication screening, such as personal or family medullary thyroid carcinoma history before GLP-1 prescribing. Verify any prescriber through the Delaware Division of Professional Regulation’s license lookup; it takes two minutes.

What Does Peptide Telehealth Cost in Delaware?

Most Delaware patients pay $96 to $349 a month. Published 2026 rates: sermorelin $96 to $250, NAD+ injections $145 to $200, compounded semaglutide $145 to $349, compounded tirzepatide $349 to $549. Brand Wegovy® lists near $1,349 a month before insurance, with Ozempic®, Mounjaro®, and Zepbound® in the same bracket.

The local alternative has always been a drive. Philadelphia-area longevity and hormone clinics charge $300 to $600 monthly for sermorelin or NAD+ protocols, before tolls and time. Telehealth delivers identical prescription compounds to a Newark or Rehoboth doorstep for a fraction of that, no I-95 required.

What Changed for Peptides in 2026?

The FDA removed BPC-157 from its Category 2 compounding concern list in April 2026, putting the most requested recovery peptide back inside the legitimate 503A pharmacy system. For Delaware’s runners and aging weekend athletes, that closed the gap that gray-market vendors had been filling.

Compounded GLP-1s reached their settled post-shortage framework: with brand semaglutide and tirzepatide in supply, 503A pharmacies compound only against documented individual clinical need, such as personalized dosing. Oral Wegovy® also gained approval, a tablet route at brand pricing for the needle-averse.

Where Delaware Demand Concentrates

Wilmington leads, with Dover, Newark, Middletown, and Smyrna behind it, and the beach towns adding seasonal demand each summer. New Castle County skews metabolic, tracking its commuter population, while Sussex County’s retiree communities ask more about NAD+ and longevity compounds. Even in a state this compact, the access pattern holds: a 2023 JAMA Network Open analysis found rural patients 28% more likely to use telehealth for chronic care once available, and southern Delaware, where specialists are thinnest, fits that profile exactly.

How to Vet Any Peptide Provider

Four questions settle it. Who is the prescriber, and does the Delaware license lookup confirm them? Which pharmacy fills the order, and is it a registered 503A or 503B facility? Can you see batch testing for your compound? What does month six cost once the intro rate expires? Research-chemical sites shipping “not for human use” vials fail every question. Every provider ranked above passes, and asking costs nothing.

The Path Forward for Delaware Patients

Pick the provider that matches the goal. For weight and metabolic health, where Delaware’s numbers run above the national median, GLP-1 peptides hold evidence nothing else in the category approaches, and TrimRx surrounds them with licensed review, documented 503A sourcing, monthly follow-up, and pricing from $199. The free assessment quiz takes five minutes; provider review usually lands within 48 hours. For recovery and longevity compounds, FormBlends and HealthRX.com carry the wider catalogs, with evidence expectations kept honest.

FAQ

Is BPC-157 Legal in Delaware in 2026?

Yes, by prescription through a licensed compounding pharmacy, following the FDA’s April 2026 removal of BPC-157 from Category 2. The literature is still dominated by animal studies (Sikiric and colleagues), so weigh claims accordingly.

Do I Need a Video Visit for Peptides in Delaware?

For a first prescription, generally yes. Section 1769D contemplates real-time audiovisual contact to establish care. Follow-ups and refills typically proceed asynchronously afterward.

Does Insurance Cover Peptide Therapy in Delaware?

Wellness peptides are cash-pay almost universally. GLP-1 coverage depends on your plan: diabetes indications are commonly covered, weight loss inconsistently. Delaware Medicaid covers GLP-1s for type 2 diabetes rather than obesity.

Are Compounded GLP-1s Still Available in 2026?

Yes, when the prescriber documents an individualized clinical need a commercial product can’t meet, such as a personalized dose. That documentation step is standard in how TrimRx writes prescriptions.

How Fast Is Shipping to Delaware?

Among the fastest in the country given East Coast pharmacy density: refrigerated delivery typically arrives in 1 to 2 days after fill, anywhere from Claymont to Fenwick Island.

Which Peptides Actually Have Evidence?

GLP-1s dominate: STEP 1 (Wilding 2021, NEJM), SURMOUNT-1 (Jastreboff 2022, NEJM), and SELECT (Lincoff 2023, NEJM, a 20% cardiovascular event cut in 17,604 patients). Sermorelin has modest older data; BPC-157 and most wellness peptides remain animal-stage.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.